Gene therapy for cancer - In the dock, blown off course or full speed ahead?

Research output: Contribution to journalReview article

3 Scopus citations


Gene therapy no longer seems to generate the unlimited optimism that it once inspired. So much so that the field has recently attracted the close scrutinies of the Director of the NIH himself. In this introductory chapter, the background is presented to the rise, and apparent decline, of the gene therapy of cancer and serves as a prelude to this issue of Cancer Metastasis Reviews which is designed to ask whether the field is worthy of its highly-priced and highly-hyped market profile.

Original languageEnglish (US)
Pages (from-to)283-286
Number of pages4
JournalCancer and Metastasis Reviews
Issue number3
StatePublished - Jan 1 1996



  • cancer
  • gene therapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this